Rigel Pharmaceuticals (NASDAQ:RIGL) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Rigel Pharmaceuticals missed estimated earnings by 14.29%, reporting an EPS of $-0.16 versus an estimate of $-0.14.

Revenue was down $64.28 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 21.12% increase in the share price the next day.

Here's a look at Rigel Pharmaceuticals's past performance:

To track all earnings releases for Rigel Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.